IL75403A - Sustained release pharmaceutical compositions containing a pyridinone derivative for oral administration - Google Patents

Sustained release pharmaceutical compositions containing a pyridinone derivative for oral administration

Info

Publication number
IL75403A
IL75403A IL75403A IL7540385A IL75403A IL 75403 A IL75403 A IL 75403A IL 75403 A IL75403 A IL 75403A IL 7540385 A IL7540385 A IL 7540385A IL 75403 A IL75403 A IL 75403A
Authority
IL
Israel
Prior art keywords
sustained release
oral administration
pharmaceutical compositions
compositions containing
medicament
Prior art date
Application number
IL75403A
Other languages
English (en)
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of IL75403A publication Critical patent/IL75403A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
IL75403A 1984-06-04 1985-06-04 Sustained release pharmaceutical compositions containing a pyridinone derivative for oral administration IL75403A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848414220A GB8414220D0 (en) 1984-06-04 1984-06-04 Medicaments in unit dose form

Publications (1)

Publication Number Publication Date
IL75403A true IL75403A (en) 1988-08-31

Family

ID=10561912

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75403A IL75403A (en) 1984-06-04 1985-06-04 Sustained release pharmaceutical compositions containing a pyridinone derivative for oral administration

Country Status (20)

Country Link
US (1) US4806361A (fr)
EP (1) EP0164959B1 (fr)
JP (1) JPS611614A (fr)
KR (1) KR920004094B1 (fr)
AT (1) ATE73323T1 (fr)
AU (1) AU573006B2 (fr)
CA (1) CA1258232A (fr)
DE (1) DE3585560D1 (fr)
DK (1) DK164259C (fr)
ES (1) ES8608863A1 (fr)
FI (1) FI87990C (fr)
GB (1) GB8414220D0 (fr)
GR (1) GR851356B (fr)
IL (1) IL75403A (fr)
MX (1) MX159928A (fr)
NO (1) NO166063C (fr)
NZ (1) NZ212268A (fr)
PH (1) PH24225A (fr)
PT (1) PT80583B (fr)
ZA (1) ZA854116B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5862314A (ja) * 1981-10-07 1983-04-13 Mazda Motor Corp 過給機付エンジンの吸気装置
JPS5993939A (ja) * 1982-11-19 1984-05-30 Toyota Motor Corp 内燃機関のノツキング制御装置
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
JPH01165520A (ja) * 1987-12-23 1989-06-29 Shin Etsu Chem Co Ltd 持続性製剤およびその製造方法
JPH07100665B2 (ja) * 1987-12-23 1995-11-01 信越化学工業株式会社 被覆薬剤の製造方法
US4880636A (en) * 1988-05-13 1989-11-14 Franz Robert M Film coated tablet of ranitidine HCl
US4938968A (en) * 1988-07-26 1990-07-03 Norjec Development Associates, Inc. Controlled release indomethacin
US5330766A (en) * 1989-01-06 1994-07-19 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
CA2007055A1 (fr) * 1989-01-06 1990-07-06 Garth Boehm Forme posologique de theophylline
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
CA2007181C (fr) * 1989-01-06 1998-11-24 Angelo Mario Morella Compose pharmaceutique a liberation continue
US5213811A (en) * 1991-09-13 1993-05-25 Sterling Drug Inc. Oral sustained-release drug compositions
JPH05149118A (ja) * 1991-11-29 1993-06-15 Mitsubishi Motors Corp エンジンの圧縮比を変化させる方法
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
ATE293440T1 (de) 1995-05-09 2005-05-15 Phoqus Pharmaceuticals Ltd Pulverbeschichtungszusammensetzung für elektrostatische beschichtung von pharmazeutischen substraten
US7008668B2 (en) 1995-05-09 2006-03-07 Phoqus Pharmaceuticals Limited Powder coating composition for electrostatic coating of pharmaceutical substrates
GB9623634D0 (en) 1996-11-13 1997-01-08 Bpsi Holdings Inc Method and apparatus for the coating of substrates for pharmaceutical use
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2758461A1 (fr) * 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
FR2795961B1 (fr) 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
PT1207860E (pt) 1999-09-02 2008-01-24 Nostrum Pharmaceuticals Inc Formulação de peletes de libertação controlada
GB0002305D0 (en) 2000-02-01 2000-03-22 Phoqus Limited Power material for electrostatic application
JP2002003366A (ja) * 2000-06-23 2002-01-09 Freunt Ind Co Ltd 固形薬剤用水系コーティング剤組成物
GB0407312D0 (en) 2004-03-31 2004-05-05 Phoqus Pharmaceuticals Ltd Method and apparatus for the application of powder material to substrates
US8298585B2 (en) * 2007-06-06 2012-10-30 Asahi Kasei Chemicals Corporation Cellulose-based fine core particle and process for producing the same
EP2744496A4 (fr) * 2011-08-16 2015-04-08 Baker Idi Heart And Diabetes Inst Holdings Ltd Formulation à libération contrôlée
EP3236963B1 (fr) 2014-12-22 2020-01-29 Cardiora Pty Ltd Procédé de traitement

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
US3328256A (en) * 1963-05-27 1967-06-27 William E Gaunt Spherical beads and their production
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
JPS50129727A (fr) * 1974-04-04 1975-10-14
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4180559A (en) * 1978-01-05 1979-12-25 Richardson-Merrell Inc. Coated 1-(2-chlorodibenzo[b,f]oxepin-10-yl)-4-methylpiperazine compositions
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
SE7813246L (sv) * 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4313951A (en) * 1979-11-26 1982-02-02 Sterling Drug Inc. 3-Substituted-6-(lower-alkyl)-5-(pyridinyl)-2(1H)-pyridinones, their cardiotonic use and intermediates therefor
NZ195564A (en) * 1979-11-26 1983-09-30 Sterling Drug Inc 5-pyridinyl-2(1h)-pyridinones pharmaceutical compositions intermediate pyridine compounds
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3126703A1 (de) * 1981-07-07 1983-01-27 Dr. Karl Thomae Gmbh, 7950 Biberach Bromhexin-retardform und verfahren zu ihrer herstellung
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
JPS58116414A (ja) * 1981-12-23 1983-07-11 Yamanouchi Pharmaceut Co Ltd ニカルジピン持続性製剤用球形顆粒およびその製造法
MX7567E (es) * 1981-12-23 1989-10-27 Yamanouchi Pharma Co Ltd Procedimiento para recubrir nicardipina de accion prolongada
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale

Also Published As

Publication number Publication date
AU4323685A (en) 1985-12-12
KR860000068A (ko) 1986-01-25
ES8608863A1 (es) 1986-07-16
GR851356B (fr) 1985-11-25
FI852235A0 (fi) 1985-06-04
FI852235L (fi) 1985-12-05
NO852225L (no) 1985-12-05
PT80583A (en) 1985-07-01
ES543826A0 (es) 1986-07-16
EP0164959A2 (fr) 1985-12-18
GB8414220D0 (en) 1984-07-11
DE3585560D1 (de) 1992-04-16
NZ212268A (en) 1988-10-28
MX159928A (es) 1989-10-06
ATE73323T1 (de) 1992-03-15
EP0164959B1 (fr) 1992-03-11
CA1258232A (fr) 1989-08-08
PT80583B (pt) 1987-09-18
PH24225A (en) 1990-04-10
DK164259C (da) 1992-10-19
FI87990B (fi) 1992-12-15
AU573006B2 (en) 1988-05-26
US4806361A (en) 1989-02-21
ZA854116B (en) 1986-01-29
NO166063C (no) 1991-05-29
DK247285A (da) 1985-12-05
JPS611614A (ja) 1986-01-07
EP0164959A3 (en) 1986-12-17
DK164259B (da) 1992-06-01
DK247285D0 (da) 1985-06-03
KR920004094B1 (ko) 1992-05-25
FI87990C (fi) 1993-03-25
NO166063B (no) 1991-02-18

Similar Documents

Publication Publication Date Title
IL75403A (en) Sustained release pharmaceutical compositions containing a pyridinone derivative for oral administration
IT8423523A0 (it) Procedimento e composizione per lapreparazione di prodotti farmaceutici ad azione prolungata controllata per la somministrazione orale.
IL63428A (en) 2-pyridyl thiazoline-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
CA2087543A1 (fr) Composes heterocycliques
ZA827745B (en) Derivatives of 3-amino pregn-5-ene,their salts,their preparation,their application as medicaments and compositions containing them
PT76573B (fr) Procede de preparation de derives d'imidazo <1,2-a> pyridine et de compositions pharmaceutiques les contenant
IL65918A (en) Water-soluble lysine and arginine salts of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxide and pharmaceutical compositions containing them
ES8403494A1 (es) "un procedimiento para la preparacion de derivados de s-adenosilmetionina".
IE851155L (en) Benzo-(pyrano and thiopyrano)-pyridines
IL87122A0 (en) Substituted thienoinidazole derivatives,process for the preparation thereof,pharmaceutical compositions containing them,and the use thereof as inhibitors of gastric acid secretion,as gastroprotectives and as medicaments for intestinal inflammations
EP0271151A3 (fr) Formes de dosage de l'azumolène
IE56229B1 (en) 2-piperazinyl-or-homopiperazinyl-quinazoline derivatives their production and pharmaceutical compositions containing them
IL69392A0 (en) Nicotinamide derivatives,their preparation and pharmaceutical compositions containing them
IL64439A0 (en) 1,2-dihydro-5-(pyridinyl)nicotinamide derivatives,their preparation and pharmaceutical compositions containing them
WO1991001963A3 (fr) Utilisation de l'acide sebacique et de ses derives dans la nutrition enterale et parenterale et compositions pharmaceutiques contenant lesdits composes
JPS54126722A (en) Slow release antibiotic tablet
DE3474962D1 (en) 2-(2-thienyl)-imidazoû4,5-b¨pyridine derivatives, pharmaceutically compatible acid addition salts of them, and process for their preparation
IL65162A0 (en) Thioalkylamide of nicotinic acid 1-oxide and its salts,their preparation and pharmaceutical compositions containing them
JPS57109722A (en) Antitumor agent containing deoxyfluorouridine benzyloxylated at 4-position
IL85508A (en) 2-substituted-4-(2-benzyl-aminophenyl)-1,4,5,7-tetra-hydro-5-oxofuro(3,4,-b)-pyridine-3-carboxylic acid derivatives and pharmaceutical compositions containing them